Study of an Investigational Product, QLS-111, Provided as an Eyedrop, for Treatment of Normal Tension Glaucoma (NTG)

NCT06030193 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Normal Tension Glaucoma (NTG)
Low-Tension Glaucoma, Bilateral
Low-Tension Glaucoma, Unspecified Eye
Glaucoma

Interventions

DRUG: QLS-111 ophthalmic solution (0.015%)
DRUG: Timolol Maleate PF 0.5% Ophthalmic Solution (Timolol)

Sponsor

Qlaris Bio, Inc.